Literature DB >> 29853341

The recent progress of isoxazole in medicinal chemistry.

Jie Zhu1, Jun Mo1, Hong-Zhi Lin1, Yao Chen2, Hao-Peng Sun3.   

Abstract

Isoxazole compounds exhibit a wide spectrum of targets and broad biological activities. Developing compounds with heterocycle rings has been one of the trends. The integration of isoxazole ring can offer improved physical-chemical properties. Because of the unique profiles, isoxazole ring becomes a popular moiety in compounds design. In this review article, the major focus has been paid to the applications of isoxazole compounds in treating multiple diseases, including anticancer, antimicrobial, anti-inflammatory, etc. Strategies for compounds design for preclinical, clinical, and FDA approved drugs were discussed. Also, the emphasis has been addressed to the future perspectives and trend for the application.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammation; Anticancer; Antimicrobial; Biological activities; Isoxazole

Mesh:

Substances:

Year:  2018        PMID: 29853341     DOI: 10.1016/j.bmc.2018.05.013

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  22 in total

Review 1.  Isocyanide-Based Multicomponent Reactions in Water: Advanced Green Tools for the Synthesis of Heterocyclic Compounds.

Authors:  Siamak Javanbakht; Mohammad Taghi Nazeri; Hassan Farhid; Tahereh Nasiriani; Vida Khodkari; Ahmad Shaabani
Journal:  Top Curr Chem (Cham)       Date:  2022-09-22

2.  Structure-Activity Relationship of Heterocyclic P2Y14 Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres.

Authors:  Young-Hwan Jung; Veronica Salmaso; Zhiwei Wen; John M Bennett; Ngan B Phung; David I Lieberman; Varun Gopinatth; John C R Randle; Zhoumou Chen; Daniela Salvemini; Tadeusz P Karcz; Donald N Cook; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2021-03-31       Impact factor: 7.446

3.  Cu/TCH-pr@SBA-15 nano-composite: a new organometallic catalyst for facile three-component synthesis of 4-arylidene-isoxazolidinones.

Authors:  Mehdi Kalhor; Seyed Mehdi Sajjadi; Akbar Dadras
Journal:  RSC Adv       Date:  2020-07-22       Impact factor: 3.361

4.  Synthesis and Biological Evaluation of Novel Isoxazole-Amide Analogues as Anticancer and Antioxidant Agents.

Authors:  Ahmad M Eid; Mohammed Hawash; Johnny Amer; Abdullah Jarrar; Samira Qadri; Iman Alnimer; Aya Sharaf; Raya Zalmoot; Osama Hammoudie; Saba Hameedi; Ahmed Mousa
Journal:  Biomed Res Int       Date:  2021-03-09       Impact factor: 3.411

5.  Regioselective synthesis of methyl 5-(N-Boc-cycloaminyl)-1,2-oxazole-4-carboxylates as new amino acid-like building blocks.

Authors:  Jolita Bruzgulienė; Greta Račkauskienė; Aurimas Bieliauskas; Vaida Milišiūnaitė; Miglė Dagilienė; Gita Matulevičiūtė; Vytas Martynaitis; Sonata Krikštolaitytė; Frank A Sløk; Algirdas Šačkus
Journal:  Beilstein J Org Chem       Date:  2022-01-12       Impact factor: 2.883

6.  Novel 3-chloro-6-nitro-1H-indazole derivatives as promising antileishmanial candidates: synthesis, biological activity, and molecular modelling studies.

Authors:  Mohamed Mokhtar Mohamed Abdelahi; Youness El Bakri; Chin-Hung Lai; Karthikeyan Subramani; El Hassane Anouar; Sajjad Ahmad; Mohammed Benchidmi; Joel T Mague; Jelena Popović-Djordjević; Souraya Goumri-Said
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

7.  Antileishmanial assessment of isoxazole derivatives against L. donovani.

Authors:  Sushobhan Mukhopadhyay; Dinesh S Barak; R Karthik; Sarvesh K Verma; Rabi S Bhatta; Neena Goyal; Sanjay Batra
Journal:  RSC Med Chem       Date:  2020-07-20

8.  Synthesis, Physicochemical Characteristics and Plausible Mechanism of Action of an Immunosuppressive Isoxazolo[5,4-e]-1,2,4-Triazepine Derivative (RM33).

Authors:  Marcin Mączyński; Andrzej Regiec; Aleksandra Sochacka-Ćwikła; Iwona Kochanowska; Maja Kocięba; Ewa Zaczyńska; Jolanta Artym; Wojciech Kałas; Michał Zimecki
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-15

Review 9.  Isoxazole Derivatives as Regulators of Immune Functions.

Authors:  Michał Zimecki; Urszula Bąchor; Marcin Mączyński
Journal:  Molecules       Date:  2018-10-22       Impact factor: 4.411

10.  Pyrrolo[2',3':3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types.

Authors:  Virginia Spanò; Roberta Rocca; Marilia Barreca; Daniele Giallombardo; Alessandra Montalbano; Anna Carbone; Maria Valeria Raimondi; Eugenio Gaudio; Roberta Bortolozzi; Ruoli Bai; Pierfrancesco Tassone; Stefano Alcaro; Ernest Hamel; Giampietro Viola; Francesco Bertoni; Paola Barraja
Journal:  J Med Chem       Date:  2020-10-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.